Phase 1, Single Dose, Crossover Study to Determine Bioequivalence and to Investigate Food Effect

NCT00807118 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

108

Enrollment

INDUSTRY

Sponsor class

Conditions

Therapeutic Equivalency
Food

Interventions

DRUG: Fesoterodine
DRUG: Fesoterodine
DRUG: Fesoterodine
DRUG: Fesoterodine
DRUG: Fesoterodine
DRUG: Fesoterodine

Sponsor

Pfizer